Tuesday, February 28, 2012

Clinical ethics support services: An evolving model.




HubMed - holistic Health





Clinical ethics support services: An evolving model.



Nurs Outlook. 2012 Feb 21;
Schlairet MC, Kiser K, Norris S

Ethical issues arising in clinical practice are complex and clinicians must be able to manage the needs of ethically vulnerable patients and families. This paper describes a model for providing Clinical Ethics Support Services as a broad spectrum of care for management of conflict and ethically difficult situations in health care and describes how an ethics consultation process was transformed to a Holistic Care Continuum for managing the needs of ethically vulnerable patients. During a 4-year journey at a regional medical center, a Family Support Team played a central role in identification of ethically vulnerable patients/family, interdisciplinary connectivity, and iterative engagement in the clinical milieu. Concepts of professional advocacy and interdisciplinary perspectives resulted in a model for ethically sound patient care promoting communication among patients/family, staff, and professionals; clarification of interdisciplinary roles and responsibilities; establishment of mutually derived goals and shared solutions; and implementation of interventions maximizing institutional resources.








YouTube Videos





Dr. Sahara's interview of Former Azusa Pacific University Running Back, Joshua Morgan









Former Crespi High School and Azusa Pacific University star running back, Joshua Morgan is getting ready for the NFL Combine. Josh learns that his level of health has everything to do with his ability to perform on and off the field. Nutrition, supplementation, as well as specific chiropractic adjustments, acupuncture without needles, cold laser therapy, ionic detoxification and hyperbaric oxygen therapy all help raise his health, increase his recovery time and maximizes his performance on the field or in the gym.

Views:
100


0
ratings
Time:
03:18
More in
Sports








YouTube Videos





ACUPUNCTURE AND ACUPRESSURE 1 , HEALTH EDUCATION , INFECTION CONTROL (ICSP) , URDU / HINDI









sehut.com http Health awareness programme by ICSP
From:
icsp94

Views:
2


0
ratings
Time:
11:06
More in
Education








HubMed - Low Level Laser therapy





Low-level laser therapy alleviates neuropathic pain and promotes function recovery in rats with chronic constriction injury-possible involvements in hypoxia-inducible factor 1α (HIF-1α).



J Comp Neurol. 2012 Feb 20;
Hsieh YL, Chou LW, Chang PL, Yang CC, Kao MJ, Hong CZ

Nerve inflammation plays an important role in the development and progression of neuropathic pain after chronic constrictive injury (CCI). Recent studies have indicated that hypoxia-inducible factor 1α (HIF-1α) is crucial in inflammation. Low-level laser therapy has been used in treating musculoskeletal pain, but rare data directly support its use for neuropathic pain. We investigated the effects of low-level laser on the accumulation of HIF-1α, tumor necrosis factor-α (TNF-α), and interleukin-1β (IL-1β) in controlling neuropathic pain, as well as on the activation of vascular endothelial growth factor (VEGF) and nerve growth factor (NGF) in promoting functional recovery in a rat CCI model. CCI was induced by placing four loose ligatures around the sciatic nerve of rats. Treatments of low-level laser (660 nm, 9 J/cm(2) ) or sham irradiation (0 J/cm(2) ) were performed at the CCI sites for seven consecutive days. The effects of laser in animals with CCI were determined by measuring the mechanical paw withdrawal threshold, as well as the sciatic, tibial, and peroneal function indices. Histopathological and immunoassay analyses were also performed.Low-level laser therapy significantly improved paw withdrawal threshold, and the sciatic, tibial, and peroneal functional indices after CCI. The therapy also significantly reduced the overexpressions of HIF-1α, TNF-α, and IL-1β, and increased the amounts of VEGF, NGF, and S100 proteins. In conclusion, a low-level laser could modulate HIF-1α activity. Moreover, it may also be used as a novel and clinically applicable therapeutic approach for the improvement of tissue hypoxia/ischemia and inflammation in nerve entrapment neuropathy, as well as for the promotion of nerve regeneration. These findings might lead to a sufficient morphological and functional recovery of the peripheral nerve. J. Comp. Neurol., 2012. © 2012 Wiley Periodicals, Inc.







No comments: